Research and Markets: Colon Cancer - Pipeline Review, H2 2013 Gives Coverage of the Colon Cancer Pipeline on the Basis of Route of Administration and Molecule Type

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/87h7jc/colon_cancer) has announced the addition of the "Colon Cancer - Pipeline Review, H2 2013" report to their offering.

Global Markets Direct's 'Colon Cancer - Pipeline Review, H2 2013' provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Colon Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Colon Cancer.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Colon Cancer.

- A review of the Colon Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery to registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

  • AEterna Zentaris Inc.
  • Advenchen Laboratories, LLC
  • Affichem
  • Alethia Biotherapeutics Inc.
  • AlphaVax, Inc.
  • Cell Therapeutics, Inc.
  • Curis, Inc.
  • Cytokinetics, Inc.
  • DEKK-TEC, Inc.
  • Eli Lilly and Company
  • Etubics Corporation
  • Five Prime Therapeutics, Inc.
  • Geistlich Pharma AG
  • ISA Pharmaceuticals B.V.
  • Isofol Medical AB
  • Kalos Therapeutics, Inc.
  • Lorus Therapeutics Inc
  • MabVax Therapeutics, Inc.
  • Northwest Biotherapeutics, Inc.
  • NovaLead Pharma Pvt. Ltd.
  • OncoMed Pharmaceuticals, Inc.
  • OncoVista Innovative Therapies, Inc.
  • Patrys Limited
  • PharmaMar, S.A.
  • Pharminox Limited
  • Pique Therapeutics
  • Tautatis Incorporated
  • Telik, Inc.
  • Transgene Biotek Ltd
  • Viventia Biotechnologies

For more information visit http://www.researchandmarkets.com/research/87h7jc/colon_cancer

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology